California State Teachers Retirement System Has $20 Billion Stock Position in CVS Health Corporation $CVS

California State Teachers Retirement System lifted its position in shares of CVS Health Corporation (NYSE:CVS) by 10,133.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 193,320,429 shares of the pharmacy operator’s stock after purchasing an additional 191,431,405 shares during the quarter. California State Teachers Retirement System owned 0.15% of CVS Health worth $19,998,998,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of CVS. Handelsbanken Fonder AB raised its stake in shares of CVS Health by 83.6% in the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock valued at $112,729,000 after buying an additional 496,124 shares in the last quarter. BNP Paribas increased its stake in CVS Health by 105.2% in the second quarter. BNP Paribas now owns 49,971 shares of the pharmacy operator’s stock valued at $5,154,000 after acquiring an additional 25,617 shares during the period. Legal & General Group Plc raised its position in CVS Health by 0.3% in the fourth quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock worth $738,777,000 after purchasing an additional 31,249 shares in the last quarter. State Street Corp raised its position in CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after purchasing an additional 1,245,457 shares in the last quarter. Finally, Deutsche Bank AG lifted its stake in CVS Health by 28.4% during the fourth quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock worth $370,333,000 after purchasing an additional 1,031,998 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. UBS Group lowered their price objective on CVS Health from $126.00 to $118.00 and set a “buy” rating on the stock in a research note on Thursday. Truist Financial boosted their price target on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. JPMorgan Chase & Co. increased their price objective on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Finally, Morgan Stanley boosted their target price on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research note on Thursday, June 4th. Twenty-two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $106.83.

CVS Health Stock Up 0.1%

Shares of NYSE:CVS opened at $96.80 on Tuesday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The firm has a market cap of $123.80 billion, a P/E ratio of 25.61, a P/E/G ratio of 0.94 and a beta of 0.59. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company’s 50-day moving average price is $100.65 and its two-hundred day moving average price is $90.35.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the previous year, the firm posted $1.81 earnings per share. The company’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.7%. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.